SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > Barron's has a $6.00 target on SQI Diagnostics

<< Previous

Bullboard Posts

Next >>

Comment by 25Stone7859on Oct 06, 2022 5:28pm

151 Views

Post# 35010747

RE:RE:RE:RE:Barron's has a $6.00 target on SQI Diagnostics

The $6 target is absurd. There is no research.
While SQI has a big suite of propretary I/P with seemingly huge potential, investors are not concinced SQI will get to the finish line. Think about:
1. RALI dx ?
2. Antibody test ?
3. TOR dx Lung ?
4. OwlStone ?
5. McMaster ?
6. PBI acquisition sales down 80% Q3 vs Q2 ?
and the big one:
6. Financing ?
SQI seems to be stalled here at $0.09 awaiting some sort of good news.Let's hope it materislizes sooner rather than later.
Good luck to all.

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?